scholarly journals [18 F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma

2015 ◽  
Vol 21 (5) ◽  
pp. 572-580 ◽  
Author(s):  
Yael Asman ◽  
Amy R. Evenson ◽  
Einat Even-Sapir ◽  
Oren Shibolet
Keyword(s):  
Computed Tomography ◽  
Hepatocellular Carcinoma ◽  
Positron Emission Tomography ◽  
Liver Transplantation ◽  
Emission Tomography ◽  
Prognostic Tool ◽  
Ablative Therapies ◽  
Positron Emission

Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant?

2017 ◽  
Vol 91 ◽  
pp. 155-159 ◽  
Author(s):  
Pedro Antonio Cascales-Campos ◽  
Pablo Ramírez Romero ◽  
Marcel André Schneider ◽  
Victor Lopez-Lopez ◽  
José Luis Navarro ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Hepatocellular Carcinoma ◽  
Positron Emission Tomography ◽  
Liver Transplantation ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma.

2021 ◽  
Author(s):  
Astrid Bauschke ◽  
Annelore Altendorf-Hofmann ◽  
Lukas Brückner ◽  
Robert Drescher ◽  
Martin Freesmeyer ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Hepatocellular Carcinoma ◽  
Positron Emission Tomography ◽  
Overall Survival ◽  
Standardized Uptake Value ◽  
Emission Tomography ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Recurrence Rates ◽  
Positron Emission ◽  
Fluorodeoxyglucose Positron Emission

Abstract Background Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio in 18 F-fluorodeoxyglucose positron emission tomography/computed tomography of the primary tumor can identify patients outside the Milan criteria with as low recurrence rates as patients inside Milan and thus should be added to the established prognostic factors. Methods This retrospective study analyzes 103 consecutive patients who underwent 18 F fluorodeoxyglucose positron emission tomography/computed tomography before liver transplantation for hepatocellular carcinoma using data of clinical tumor registry. Primary endpoints were overall survival and 10-year cumulative recurrence rates. Results Tumor to liver standardized uptake value ratio of the primary tumor was statistically significant higher in Milan out tumors, “up-to-seven” out tumors, grade 3 tumors, alpha-fetoprotein level >400 ng/ml and lesions upwarts 5cm in diameter. Factors with statistically significant influence on the 10-year overall survival in the univariate analysis were Milan, up-to-seven” criteria, number of lesions and pT-category. COX regression analysis did not show independently statistically significant factors for 10-year overall survival. Milan, “up-to-seven” criteria, grade, pV, number of lesions, size of lesion, pT-category, tumor to liver standardized uptake value ratio influenced 10-year cumulative recurrence rates statistically significantly. Tumor to liver standardized uptake value ratio, grade and pT-category proved to be independently statistically significant factors for 10-year cumulative recurrence rates. Conclusions Our study suggests that tumor to liver standardized uptake value standardized uptake value ratio in 18 F-fluorodeoxyglucose positron emission tomography/computed tomography is an independent prognostic factor in transplanted patients with hepatocellular carcinoma and might be helpful in estimating the risk of recurrence for patients scheduled for liver transplantation.

Sign in / Sign up

Export Citation Format

Share Document